Are you a fan of small cap shares like I am? If you are, then you might want to look closely at two that are listed below.
Here's what you need to know about them:
MyDeal.com.au Limited (ASX: MYD)
The first small cap ASX share to look at is MyDeal.com.au. It is growing online retail marketplace with a focus on furniture, homewares, and kitchen and bathroom products.
It has been growing very strongly over the last 12 months thanks to the accelerating shift to online shopping.
For example, during the six months ended 31 December, MyDeal reported a 217% increase in gross sales to $126.7 million and a 248% jump in revenue to $21.2 million. And while its gross margin softened slightly, its gross profit still grew at the very strong rate of 210% to $18.9 million.
Management advised that this was driven by a 205% increase in active customers to 813,764 and further improvements in repeat use. In respect to the latter, a total of 52.7% of second quarter transactions came from returning customers. This is up from 38.5% a year earlier.
One broker that was pleased was Morgans. It has retained its add rating and $1.70 price target on the company's shares.
Nitro Software Ltd (ASX: NTO)
Another small cap ASX share to look at is Nitro Software. It is a growing software company which is helping to drive digital transformation in businesses around the world across multiple industries.
The key product in the company's offering is the Nitro Productivity Suite. This solution provides businesses with integrated PDF productivity and electronic signature tools via a software-as-a-service and desktop-based software solution.
Late last month the company released its full year results and revealed annual recurring revenue (ARR) of $27.7 million. This was up 64% year on year and ahead of its upgraded guidance range of $26 million to $27 million.
Looking ahead, another strong year is expected in FY 2021. Management revealed that it expects FY 2021 ARR to be between $39 million and $42 million. This represents year on year growth of 41% to 51.6%.
This went down well with Morgan Stanley, which retained its overweight rating and $3.50 price target.
